Know Cancer

or
forgot password

Use of Multiphoton Microscopy in the Diagnosis of Cancer


Phase 1
21 Years
85 Years
Open (Enrolling)
Both
Bladder Cancer, Prostate Cancer

Thank you

Trial Information

Use of Multiphoton Microscopy in the Diagnosis of Cancer


Same as above


Inclusion Criteria:



- Anyone who presents with bladder and/or prostate cancer

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

After several delays, the multiphoton microscope has been delivered to Weill Cornell Medical College. We have been using this time to set-up and fine tune the multiphoton microscope. As of current, no negative events have occurred.

Outcome Time Frame:

10/14/2007 to 2/15/2008

Safety Issue:

No

Principal Investigator

Douglas S Scherr, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Weill Medical College of Cornell University

Authority:

United States: Institutional Review Board

Study ID:

0506007919

NCT ID:

NCT00652210

Start Date:

October 2007

Completion Date:

March 2010

Related Keywords:

  • Bladder Cancer
  • Prostate Cancer
  • Bladder cancer
  • prostate cancer
  • multiphoton microscopy
  • Urinary Bladder Neoplasms
  • Prostatic Neoplasms

Name

Location

Weill Cornell Medical CollegeNew York, New York  10021